Related by context. All words. (Click for frequent words.) 75 recurrence 65 tumor recurrence 63 distant metastases 61 metastases 60 relapses 60 chemoradiation 59 chemoradiotherapy 58 reoccurrence 58 thromboembolic events 57 hemorrhagic complications 57 locoregional recurrence 57 relapse 57 ipsilateral breast 57 thrombotic events 57 metastatic disease 56 Recurrences 56 febrile neutropenia 56 GISTs 56 CDI recurrence 56 endometrial cancers 56 breast cancer recurrences 56 metastatic lesions 56 ipsilateral stroke 56 ALND 56 liver metastases 56 distant metastasis 55 advanced adenomas 55 syncopal 55 malignancies 55 EBRT 55 gout flares 55 curative resection 55 recurrent VTE 55 tumor shrinkage 55 endometrial carcinoma 55 nonmelanoma skin cancers 55 androgen deprivation 55 adjuvant radiation 55 basal cell carcinomas 55 debulking surgery 55 axillary dissection 55 Recurrence 55 leiomyosarcoma 54 gastrointestinal cancers 54 thrombotic complications 54 contralateral breast 54 chronic GVHD 54 recurrent myocardial infarction 54 cerebral vasospasm 54 endophthalmitis 54 corticosteroid therapy 54 variceal bleeding 54 upon rechallenge 54 postoperative chemotherapy 54 repigmentation 54 liver resection 54 differentiated thyroid 54 underwent resection 54 peritoneal cancer 54 allograft rejection 54 MIs 54 bladder cancers 54 GIST tumors 54 pulmonary metastases 54 hematologic toxicity 53 hematologic adverse 53 osteosarcomas 53 metastatic tumors 53 vertebral fracture 53 brain metastases 53 breast carcinoma 53 postoperative complications 53 CMV disease 53 perioperative complications 53 venous blood clots 53 VT VF 53 metastatic cancer 53 reinfarction 53 lesions 53 thromboembolic 53 cystectomy 53 androgen suppression 53 node metastases 53 breast cancer recurrence 53 GI bleeds 53 thyroid nodules 53 invasive carcinoma 53 delayed CINV 53 renal tumors 53 reoccurrences 53 cerebrovascular events 53 nonmetastatic 53 adjuvant radiotherapy 53 reoperations 53 adenomatous polyps 53 neoadjuvant 53 hepatic metastases 53 squamous cell cancers 53 Adjuvant chemotherapy 53 precursor lesions 53 postoperative atrial fibrillation 53 PSADT 53 bone metastasis 53 locoregional 53 cytoreduction 53 lymphadenectomy 53 CMV infections 53 advanced adenoma 53 hormonal therapy 53 epithelial tumors 53 lymph node dissection 53 severe hypoglycemic 53 neoadjuvant chemotherapy 53 adjuvant therapy 52 metachronous 52 MACCE 52 spontaneous remission 52 tumor resection 52 surgical debulking 52 postoperative AF 52 neoplasms 52 micrometastases 52 nonvertebral fractures 52 stent thromboses 52 acute coronary 52 contralateral breast cancer 52 bowel cancers 52 recurrent prostate cancer 52 androgen suppression therapy 52 colectomy 52 operable breast cancer 52 Toxicities 52 severe exacerbations 52 basal cell cancers 52 repeat revascularization 52 DVT PE 52 venous thromboembolic 52 rebleeding 52 HNSCC 52 renarrowing 52 intracerebral hemorrhage 52 HBeAg seroconversion 52 mycophenolate mofetil 52 recurrent DVT 52 anterior uveitis 52 Relapses 52 postop 52 microvascular complications 52 postoperative infections 52 paroxysmal AF 52 cytogenetic responses 52 anaplastic 52 refractory ischemia 52 neoadjuvant chemoradiotherapy 52 femoral neck fractures 52 postoperative mortality 52 colorectal adenoma 52 revascularization procedures 52 lymph node removal 52 TEAEs 52 heterotopic ossification 52 preoperative chemotherapy 51 bisphosphonate therapy 51 axillary node dissection 51 malignant neoplasm 51 concomitant antibiotics 51 Thal Dex 51 Sentinel node biopsy 51 retreatment 51 lymph node involvement 51 anastomotic leak 51 nonoperative 51 cytoreductive surgery 51 CMV infection 51 invasive cervical cancer 51 complete remissions 51 pancreatic adenocarcinoma 51 breast conserving lumpectomy 51 precancerous cervical lesions 51 postoperative complication 51 spinal cord compression 51 mycobacterial infections 51 palliation 51 liver metastasis 51 tumor regressions 51 pneumonectomy 51 intravenous bisphosphonates 51 proximal DVT 51 rehospitalization 51 total thyroidectomy 51 leiomyomas 51 cranial irradiation 51 cranial radiation 51 NMIBC 51 hypertrophic scars 51 resection 51 lymph node metastasis 51 malignancy 51 fragility fractures 51 variceal 51 amenorrhoea 51 venous thromboembolism 51 recanalization 51 antiplatelet therapy 51 Brain metastases 51 asthma exacerbations 51 cutaneous squamous cell carcinoma 51 inhospital 51 fallopian tube cancers 51 renal scarring 51 radioiodine therapy 51 nodal metastases 51 vertebral fractures 51 endometrial hyperplasia 51 neoadjuvant therapy 51 intraperitoneal therapy 51 intravitreal injections 51 polyposis 51 contrast induced nephropathy 51 mesotheliomas 51 lobular cancer 51 revascularisation 51 invasive aspergillosis 51 salpingo oophorectomy 51 carcinomas 51 evaluable patients 51 nephron sparing surgery 51 EXJADE 51 testicular cancers 51 breast cancers 51 ischemic complications 51 superficial bladder cancer 51 androgen ablation 51 toxicities 51 Partial Responses 51 tumor lysis syndrome 51 ximelagatran 51 tumor regression 51 asymptomatic AF 51 symptom flare ups 51 abnormal mammograms 51 carotid stenosis 51 ICD shocks 51 ocular toxicity 51 nodular melanoma 51 gout flare 50 upper gastrointestinal bleeding 50 stenting 50 lipomas 50 malignant neoplasms 50 biochemical relapse 50 invasive fungal infection 50 adjuvant chemotherapy 50 severe neutropenia 50 gastrointestinal toxicity 50 EUS FNA 50 hepatotoxicity 50 curable cancers 50 ruptured aneurysms 50 tamoxifen therapy 50 neurologic complications 50 metastasis 50 colorectal cancers 50 infusion reactions 50 Clostridium difficile infections 50 recurrent venous thromboembolism 50 thromboembolic disease 50 nonoperative treatment 50 imatinib therapy 50 carcinoid tumor 50 preventive mastectomy 50 hypercalcemia 50 metastatic lung cancer 50 precancerous condition 50 nonmelanoma skin cancer 50 postoperative radiotherapy 50 carcinoma 50 complete cytogenetic 50 biochemical recurrence 50 proliferative diabetic retinopathy 50 reblockage 50 biopsies 50 pre cancerous lesions 50 radical nephrectomy 50 acute GVHD 50 transitional cell carcinoma 50 basal cell carcinoma BCC 50 pathologic fractures 50 prolonged QT interval 50 invasive ductal carcinoma 50 follicular lymphoma 50 patients evaluable 50 gastrointestinal perforation 50 Hurthle cell 50 Tumor shrinkage 50 diverticular bleeding 50 CCyR 50 S. aureus infections 50 oophorectomy 50 thromboembolism 50 ALT flares 50 aromatase inhibitor therapy 50 atypical fractures 50 lung metastases 50 postoperative morbidity 50 aneurysm rupture 50 precancerous polyp 50 lymph node metastases 50 malignant melanomas 50 FOLPI 50 colon tumors 50 PCNSL 50 reinfection 50 recurrent 50 reoperation 50 urothelial cancer 50 colorectal liver metastases 50 chemo radiotherapy 50 adenoma 50 venous thrombosis 50 bone metastases 50 subtrochanteric 50 cervical lymph nodes 50 dysplastic lesions 50 ductal cancer 50 sarcomas 50 Febrile neutropenia 50 colorectal adenomas 50 perioperative mortality 50 benign nodules 50 radical prostatectomy RP 50 femur fractures 50 Erythropoietic therapies may 49 cervical intraepithelial neoplasia 49 abnormal Pap smears 49 lumbar disk herniation 49 fibrinolysis 49 urinary bladder cancer 49 mucositis 49 PASI scores 49 adrenalectomy 49 intestinal metaplasia 49 lichen planus 49 symptomatic atrial fibrillation 49 colon cancers 49 recurrent metastatic 49 sustained virologic response 49 lymph nodes 49 antithrombotic therapy 49 Radical prostatectomy 49 incidence ≥ 49 neutropenic 49 recurrent ischemia 49 HBeAg negative 49 grade gliomas 49 stent implantation 49 neoadjuvant treatment 49 spontaneous preterm birth 49 heavily pretreated 49 invasive breast cancer 49 tumor regrowth 49 venous thromboembolic events 49 chronic rhinosinusitis 49 pCR 49 mastectomy 49 myocardial infarctions 49 TURP 49 spontaneous preterm delivery 49 ocular adverse 49 irinotecan chemotherapy 49 radiotherapy RT 49 melanomas 49 leucopenia 49 disease progression 49 femoral neck fracture 49 ovarian cancers 49 thymoma 49 grade dysplasia 49 keloids 49 cisplatin 49 gastrointestinal bleeds 49 post thrombotic syndrome 49 varicella infection 49 postsurgical 49 heavily pretreated patients 49 zoledronic acid 49 HCV infection 49 VTE 49 relapsing remitting 49 papillary thyroid carcinoma 49 pre cancerous polyps 49 hyperacute 49 pre cancerous growths 49 hamartomas 49 breast conserving 49 oral anticoagulant therapy 49 laboratory abnormalities 49 ALCL 49 thoracoscopic lobectomy 49 OAB symptoms 49 menstrual migraines 49 recurrent UTIs 49 severe hypersensitivity reactions 49 benign polyps 49 cutaneous melanoma 49 keloid 49 deep vein thromboses 49 axillary nodes 49 gastrointestinal toxicities 49 angiosarcoma 49 chlamydial infection 49 reinterventions 49 benign proliferative breast 49 recurrent bladder 49 colorectal neoplasms 49 surgical excision 49 amyloid deposition 49 metastatic bone 49 urethral strictures 49 transurethral resection 49 squamous cell carcinoma SCC 49 node dissection 49 nonfatal MI 49 tumors 49 virologic failure 49 spontaneous bacterial peritonitis 49 metastatic bladder 49 uveal melanoma 49 cryptogenic stroke 49 fallopian tube carcinoma 49 vaginal hysterectomy 49 squamous cell cancer 49 parkinsonian symptoms 49 nephrotoxicity 49 colorectal polyp 49 sentinel node biopsy 49 uterine cancers 49 autoimmune reactions 49 platelet reactivity 49 neutropaenia 49 invasive ductal 49 ovarian cancer 49 anthracycline taxane 49 perioperative morbidity 49 thyrotoxicosis 49 histologically proven 49 CR nPR 49 hypoglycaemic episodes 49 BCCs 49 liver biopsies 49 infective endocarditis 49 nonadherence 49 cholecystectomy 49 chorioamnionitis 49 resectable 49 intraoperative complications 49 PCIs 49 dysmenorrhoea 49 metastatic RCC 49 hypoglycemic events 49 nasal polyps 49 bowel resection 49 vaccinees 49 unresectable 49 postoperative infection 49 intestinal polyps 48 skeletal metastases 48 cancerous growths 48 Metastatic 48 reflux symptoms 48 strep infections 48 cisplatin chemotherapy 48 coronary intervention 48 atherosclerotic disease 48 Doxil ® 48 colorectal cancer 48 prophylactic mastectomies 48 basal cell skin 48 cholecystitis 48 undergoing radical prostatectomy 48 polyps 48 stage IIIB 48 fragility fracture 48 Candida infection 48 hippocampal atrophy 48 Surgical excision 48 ovarian tumors 48 recurrent miscarriages 48 grade cervical intraepithelial 48 catheter angiography 48 rechallenge 48 prophylactic mastectomy 48 intravesical therapy 48 median PFS 48 KIT mutations 48 cerebrovascular accidents 48 wound dehiscence 48 cholangiocarcinoma 48 allogeneic HSCT 48 lymphocytosis 48 rehospitalizations 48 systemic toxicity 48 genital herpes infections 48 perioperatively 48 adalimumab 48 pT2 48 radiation therapy 48 recurrent stroke 48 neuroendocrine tumors 48 medically inoperable 48 prior chemotherapy regimens 48 octreotide LAR 48 clinically evaluable patients 48 enzyme elevations 48 myocardial infarction MI 48 malignant lesions 48 unresectable stage 48 onset sepsis 48 lung nodules 48 hematological adverse 48 pericardial effusions 48 symptomatic VTE 48 ADPKD 48 FOLFOX4 48 cancers 48 undergoing hysterectomy 48 malperfusion 48 hepatectomy 48 onset atrial fibrillation 48 Helicobacter pylori infection 48 generalized seizures 48 ductal breast cancer 48 C. difficile diarrhea 48 Venous thromboembolism 48 COPD exacerbations 48 SLNB 48 definite stent thrombosis 48 pleural mesothelioma 48 myelosuppression 48 Colon polyps 48 invasive coronary angiography 48 axillary node 48 CIN3 48 benign breast 48 ticlopidine 48 cytogenetic response 48 radicular pain 48 adenocarcinomas 48 colorectal polyps 48 neuroendocrine cancers 48 breast carcinomas 48 dasatinib 48 chemoembolization 48 nephrectomy 48 overt hepatic encephalopathy HE 48 atrial arrhythmias 48 meniscal tears 48 papillary thyroid cancer 48 pulmonary metastasis 48 gastric corpus 48 neurologic sequelae 48 lumpectomies 48 arteriography 48 posttraumatic arthritis 48 esophageal cancers 48 arterial thromboembolic events 48 cilostazol 48 seminoma 48 pseudoaneurysms 48 solar keratoses 48 extrapleural pneumonectomy 48 paragangliomas 48 adjuvant therapies 48 neoplasia 48 progression TTP 48 unruptured aneurysms 48 angioedema 48 pelvic lymphadenectomy 48 interferon ribavirin 48 C. difficile infection 48 exacerbations 48 invasive candidiasis 48 oral clodronate 48 VUR 48 severe oral mucositis 48 complete cytogenetic response 48 grade glioma 48 venous thromboembolisms 48 neoplastic lesions 48 hypoglycemic episodes 48 axillary lymph node dissection 48 plus methotrexate 48 invasive carcinomas 48 bronchial thermoplasty 48 unresectable tumors 48 flare ups 48 thyroid cancers 48 prostate cancer CaP 48 TACE 48 recurrent genital herpes 48 treatment emergent adverse 48 IV bisphosphonates 48 fluorouracil 48 discontinuations due 48 HER2 negative 48 carcinoid tumors 48 micrometastasis 48 tumor metastases 48 melanoma 48 placebo dexamethasone 48 acute aortic dissection 48 melanoma lesions 48 myocardial infarction 48 lymphopenia 48 streptococcal infections 48 5-FU/LV 48 precancers 48 hyperkalemia 48 Ishak fibrosis score 48 cytotoxic chemotherapy 48 MGUS 48 gastroduodenal 48 impingement syndrome 48 mg kg dose 48 cystic lesions 48 colorectal tumors 48 sentinel nodes 48 HSCT 48 anthracycline containing 48 spine fractures 48 abnormal pap smears 48 esophageal perforation 48 FluCAM arm 48 malignant growths 48 orchitis 48 pericardial effusion 48 hyperalgesia 48 anticoagulant therapy 48 chronic urticaria 48 neuropsychiatric symptoms 48 acute GvHD 48 hormone receptor negative 48 HBeAg positive patients 48 sequelae 48 postherpetic neuralgia 48 coronary blockages 48 dexrazoxane 48 esophagitis 48 lung tumors 48 intensive statin therapy 48 preventive mastectomies 48 sustained ventricular tachycardia 48 H. pylori infections 48 undergoing CABG 48 T1c 48 DLBCL 48 metastatic malignant melanoma 48 hematological toxicities 48 virological failure 48 DMARD therapy 48 tamoxifen 48 squamous cell 48 Carcinoma 48 chlorambucil 48 histologic subtype 48 EGFRIs 48 acute gout flares 48 TNF blocker therapy 48 osteoid osteoma 48 gouty arthritis 48 seminomas 47 recurred 47 radiochemotherapy 47 recurrent glioblastoma multiforme 47 virological response 47 adenomas 47 nodal metastasis 47 C. difficile infections 47 epithelial ovarian 47 BRCA2 mutation carriers 47 GERD symptoms 47 prophylactic cranial irradiation 47 hip fractures 47 fibrocystic disease 47 GnRH agonists 47 BRCA deficient 47 anticoagulants blood thinners 47 histologically confirmed 47 thyroid carcinoma 47 thromboses 47 zalutumumab 47 neurologic deficits 47 sentinel lymph node biopsy 47 hypersensitivity reaction 47 herpes zoster infection 47 neutropenic fever 47 thromboprophylaxis 47 acute rhinosinusitis 47 basal cell nevus syndrome 47 completely resected 47 carcinoid 47 sarcoma 47 MALT lymphoma 47 lobectomy 47 ischemic cardiomyopathy 47 ventricular arrhythmias 47 pheochromocytoma 47 chlamydial infections 47 Metastases 47 underwent surgical resection 47 severe hypoglycemia 47 pleural effusion 47 evaluable 47 bilateral oophorectomy 47 stage IIIA 47 colorectal carcinoma 47 postoperative 47 acute myocardial infarctions 47 neoplasias 47 anastrozole 47 thyroiditis 47 exemestane 47 fibrinolytic 47 graft occlusion 47 malignant pleural mesothelioma 47 ALA PDT 47 reperfusion injury 47 infusional 47 pre cancerous cells 47 urothelial bladder cancer 47 undergone radical prostatectomy 47 hypoperfusion 47 thyroidectomy 47 AGILECT R 47 spontaneous regression 47 cabazitaxel 47 mammary tumors 47 cerebral infarction 47 nasopharyngeal cancer 47 esophagogastric junction 47 ductal carcinomas 47 breast endometrial 47 prostate adenocarcinoma 47 bowel perforation 47 advanced HER2 positive 47 gastrectomy 47 pulmonary dysfunction 47 prodromal symptoms 47 trabeculectomy 47 intra arterial chemotherapy 47 thromboembolic complications 47 erythema redness 47 aortic rupture 47 polypectomy 47 ovarian carcinoma 47 skin cancers 47 HoLEP 47 receiving VELCADE 47 Hypocalcemia 47 cancerous lesions 47 adenomatous 47 polycythemia vera 47 Progressive Multifocal Leukoencephalopathy PML 47 RALP 47 thrombo embolic 47 sustained virological response 47 eribulin 47 oncologic outcomes 47 postoperative pain 47 pancreatic resection 47 ischemic cerebrovascular 47 colon polyps 47 uterine fibroid 47 recurrent atrial fibrillation 47 prostate cancers 47 familial ALS 47 cT3 prostate cancer 47 osteoporotic fractures 47 Median survival 47 FOLFIRI 47 varices 47 hormone deprivation 47 vesicoureteral reflux 47 cervical lesions 47 gastro oesophageal reflux disease 47 inflammatory lesions 47 colorectal cancer CRC 47 Squamous cell carcinomas 47 renal flares 47 pleural effusions 47 spinal metastases 47 pilocytic astrocytoma 47 invasive lobular carcinoma 47 hip fracture 47 GI bleeding 47 testicular tumors 47 potentially cancerous polyps 47 BRCA mutation carriers 47 staphylococcal infections 47 5FU 47 recurrent infections 47 Hypotension 47 corneal infection 47 femoral fracture 47 interstitial pneumonia 47 squamous cell carcinomas 47 external genital lesions 47 malignant brain 47 hemodynamic instability 47 metastatic 47 colon rectal cancer 47 mitral regurgitation 47 hydroxychloroquine 47 premalignant lesions 47 mycosis fungoides 47 vasospasm 47 morphometric vertebral fractures 47 esophageal tumors 47 colorectal adenocarcinoma 47 precancerous lesion 47 moderately emetogenic cancer 47 Wilms tumors 47 esophageal carcinoma 47 Cristofanilli 47 radiotherapy 47 rectal cancer 47 epithelial ovarian cancer 47 MS relapses 47 revascularizations 47 papillary renal cell carcinoma 47 pre cancerous 47 thrombosis 47 infarcts 47 bladder tumors 47 adenoidectomy 47 systemic scleroderma 47 hepatic resection 47 infliximab 47 pH#N# 47 visceral metastases 47 FOLFOX 47 prostate cancer PCa 47 corticosteroid injection 47 Hematologic toxicity 47 PONV 47 neurocognitive deficits 47 pegylated liposomal doxorubicin 47 glioblastomas 47 bacteriuria 47 cardiotoxic effects 47 hypopituitarism 47 beta blocker therapy 47 TMP SMX 47 toxicities commonly 47 hormonal therapies 47 response pCR 47 conventional angiography 47 MMP inhibitors 47 ABVD 47 curative therapy 47 sternal wound infections 47 CaP 47 occult metastases 47 postoperative pulmonary 47 lobular breast cancer 47 endoleaks 47 hepatocellular carcinoma 47 Postoperative complications 47 rindopepimut 47 cardiac toxicity 47 liver transplant recipients 47 adverse cytogenetics 47 hemoptysis 47 relapsed ovarian cancer 47 immunosuppression 47 herpetic 47 gastric cancer 47 lung metastasis 47 medullary thyroid cancer 47 Anaphylactic reactions 47 peritoneal carcinomatosis 47 serous ovarian cancer 47 sacral neuromodulation 47 synovial sarcoma 47 angiographic restenosis 46 femoral shaft fractures 46 nasopharyngeal carcinoma 46 platelet transfusions 46 squamous cell lung cancer 46 CYPHER Stent 46 recurrent glioblastoma 46 pulmonary resection 46 esophageal squamous cell carcinoma 46 BRCA1 mutation carriers 46 adjuvant tamoxifen 46 pituitary adenomas 46 atypical femur fractures 46 bilateral mastectomy 46 reccurrence 46 ECG abnormalities 46 vulvar intraepithelial neoplasia 46 EBV infection 46 HGPIN 46 BRCA mutations 46 pelvic malignancies 46 endovascular repair 46 post operatively 46 achieved ACR# 46 axillary lymph nodes 46 mitoxantrone 46 squamous cell carcinoma 46 aortic coarctation 46 PCa 46 postoperative bleeding 46 recurrent coronary 46 gastric adenocarcinoma 46 undergoing cardiac catheterization 46 ocular melanoma 46 #Gy 46 dysplasia 46 eosinophilic pneumonia 46 Graves ophthalmopathy 46 squamous cell skin 46 posttraumatic 46 intraoperative bleeding 46 nocturnal hypoglycaemia 46 TNF antagonist 46 breast uterine 46 ectasia 46 concurrent chemoradiation 46 ribavirin RBV 46 ventricular arrhythmia 46 incisional hernias 46 reflux disease 46 genital ulcers 46 patients undergoing CABG 46 abdominal hysterectomy 46 severe rotavirus gastroenteritis 46 anemia neutropenia 46 HER2 overexpression 46 CMV reactivation 46 symptomatic intracranial 46 gastric cancers 46 recurrent GBM 46 epirubicin 46 pelvic radiotherapy 46 Hodgkin lymphoma HL 46 extracapsular extension 46 symptomatic paroxysmal AF 46 leukopenia 46 Glioblastoma Multiforme 46 laparoscopically assisted 46 abnormal Pap tests 46 carotid endarterectomy 46 immunosuppressed patients 46 radiographic progression 46 nonsurgical treatment 46 histologic 46 rectal cancers 46 cetuximab 46 percutaneous drainage 46 Carotid endarterectomy 46 prostatectomy 46 lymphoma 46 related hematological toxicity 46 ERCP 46 atypia 46 neurofibromas 46 coronary artery bypass grafts 46 meningiomas 46 tamoxifen Nolvadex ® 46 HPV infections 46 lymph node enlargement 46 precancerous cervical 46 hypophosphatemia 46 RET PTC rearrangements 46 taxane therapy 46 induce remission 46 optic neuritis 46 H. pylori eradication 46 CLL SLL 46 adriamycin 46 oral corticosteroids 46 chemotherapy docetaxel 46 CR CRu 46 benign lesions 46 external beam radiotherapy 46 recurrent urinary tract infection 46 mg/m2 dose 46 soft tissue sarcomas 46 ICD implantation 46 Thrombocytopenia 46 cervical dysplasia 46 femoral shaft fracture 46 incontinence episodes 46 pheochromocytomas 46 infarct size 46 radiographic findings 46 retransplantation